Stocks
GlaxoSmithKline (GSK) OPEX US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| OPEX, £ | 16 310 000 000 | 13 337 000 000 | 13 337 000 000 | 15 377 000 000 | 14 259 000 000 | 16 693 000 000 | |||
| Changes by years, y/y, % | 0% | -18% | 0% | +15% | -7% | -1.1% | |||
GlaxoSmithKline. OPEX, £
GlaxoSmithKline. OPEX, changes, %
GlaxoSmithKline. OPEX, sum by quarters, £
GlaxoSmithKline (GSK) OPEX US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| OPEX, £ | 3 105 000 000 | 3 926 000 000 | 4 662 000 000 | 4 662 000 000 | 3 443 000 000 | 16 693 000 000 | ||
| Changes by years, y/y, % | -15% | -7% | +43% | +43% | +18% | |||
| Changes by quarters, q/q, % | 0% | +26% | +19% | 0% | -26% | |||
